Simplex Trading
PVLA

Simplex Trading’s Palvella Therapeutics PVLA Stock Holding History

Simplex Trading’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$202K Buy
+1,622
New +$169K ﹤0.01% 4282
2023
Q1 		– Sell
-6
Closed -$695 – 10337
2022
Q4 		$0 Hold
6
– – ﹤0.01% 10684
2022
Q3 		$0 Sell
6
-76
-93% -$9.8K ﹤0.01% 11072
2022
Q2 		$12K Buy
+82
New +$15K ﹤0.01% 8157
2022
Q1 		– Sell
-9
Closed -$2.37K – 11576
2021
Q4 		$2K Sell
9
-502
-98% -$161K ﹤0.01% 10086
2021
Q3 		$157K Hold
511
– – ﹤0.01% 5983
2021
Q2 		$156K Buy
+511
New +$112K ﹤0.01% 6083
2020
Q4 		– Sell
-43
Closed -$7K – 9217
2020
Q3 		$7K Buy
43
+39
+975% +$8.88K ﹤0.01% 6983
2020
Q2 		$0 Buy
+4
New +$935 ﹤0.01% 8525
2019
Q4 		– Sell
-180
Closed -$49.9K – 8092
2019
Q3 		$49K Buy
180
+175
+3,500% +$67.8K ﹤0.01% 5042
2019
Q2 		$1K Buy
+5
New +$1.49K ﹤0.01% 6923
2018
Q2 		– Sell
-1
Closed – – 7981
2018
Q1 		$0 Buy
+1
New +$619 ﹤0.01% 7006

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Simplex Trading's PVLA Position: Q1 2026 in Review

Simplex Trading opened a new position in Palvella Therapeutics (PVLA) in Q1 2026: 1,622 shares worth $202K. The stake represents ﹤0.01% of the portfolio and ranks #4282 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PVLA as recently as Q4 2022.

Simplex Trading first reported a position in PVLA in Q1 2018 and has held it in 12 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Simplex Trading held 1,622 shares of Palvella Therapeutics worth $202K as of Q1 2026.
  • Palvella Therapeutics was a new Simplex Trading position in Q1 2026.
  • Palvella Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4282 holding.
  • Simplex Trading first reported a position in Palvella Therapeutics in Q1 2018 and has held it in 12 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.